Indivior PLC (NASDAQ:INDV) Shares Purchased by Melqart Asset Management UK Ltd

Melqart Asset Management UK Ltd raised its holdings in shares of Indivior PLC (NASDAQ:INDV - Free Report) by 675.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 104,790 shares of the company's stock after acquiring an additional 91,280 shares during the period. Melqart Asset Management UK Ltd owned approximately 0.08% of Indivior worth $1,303,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of INDV. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Indivior during the 4th quarter valued at approximately $56,000. Stifel Financial Corp purchased a new stake in shares of Indivior during the third quarter worth $100,000. Jane Street Group LLC purchased a new stake in shares of Indivior during the third quarter worth $180,000. Rathbones Group PLC grew its holdings in shares of Indivior by 11.6% during the fourth quarter. Rathbones Group PLC now owns 14,284 shares of the company's stock worth $183,000 after buying an additional 1,483 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. purchased a new stake in shares of Indivior during the fourth quarter worth $359,000. 60.33% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on INDV shares. RODMAN&RENSHAW raised shares of Indivior to a "strong-buy" rating in a report on Tuesday, January 28th. Rodman & Renshaw started coverage on shares of Indivior in a report on Tuesday, January 28th. They set a "buy" rating and a $16.00 target price for the company. Finally, Piper Sandler dropped their target price on shares of Indivior from $16.00 to $13.00 and set an "overweight" rating for the company in a report on Thursday, March 6th.

Indivior Stock Down 2.0 %

Shares of Indivior stock traded down $0.24 during mid-day trading on Wednesday, hitting $11.51. The stock had a trading volume of 748,537 shares, compared to its average volume of 976,951. The firm has a 50-day moving average of $9.55 and a two-hundred day moving average of $10.38. The firm has a market cap of $1.59 billion, a P/E ratio of -32.89 and a beta of 0.93. Indivior PLC has a 12-month low of $7.33 and a 12-month high of $18.59.

Indivior (NASDAQ:INDV - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.22 by $0.19. The business had revenue of $266.00 million during the quarter, compared to the consensus estimate of $240.13 million. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. Sell-side analysts expect that Indivior PLC will post 1.22 earnings per share for the current year.

Indivior Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.